FeaturesSignalPricingFounders
BI

Bioventures Investors

Venture CapitalActive

Bioventures Investors is an investment firm focused on the commercial development of advanced technology in life sciences and healthcare.

Wellesley, United StatesFounded 2012bioventuresinvestors.com/
32
Investments
8
Exits
$205M
AUM
25.0%
Exit Rate

Get contact info, warm intros & fit scores

Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Bioventures Investors.

Get started free

Investment Thesis & Strategy

Bioventures Investors invests in various stages of healthcare and life science companies with advanced technologies, focusing on commercial development.

Investment Activity

Deals per year over the last 9 years

1
2013
1
2014
2
2015
1
2016
0
2017
3
2018
2
2019
0
2020
2
2021

Portfolio Companies

Selected investments from their portfolio of 32 companies

I
Inceptor Bio
Biotech · Series A, 2021
Active
O
Obsidio
Biotech · Series A, 2021
Active
T
Tvardi Therapeutics
Biotech · Series A, 2019
Active
X
Xilio Therapeutics
Biotech · Series A, 2019
Active
T
Triumvira Immunologics
Biotech · Series A, 2018
Active
V
Vaxcyte
Biotech · Series B, 2018
Active
T
TScan Therapeutics
Biotech · Series A, 2018
Active
C
Codiak BioSciences
Biotech · Series B, 2016
Active
K
Kiadis Pharma
Biotech · Growth, 2015
Active
I
Immatics
Biotech · Series B, 2015
Active
R
Rgenix
Biotech · Series A, 2014
Active
A
Aeglea BioTherapeutics
Biotech · Series A, 2013
Active

Frequently Asked Questions

Bioventures Investors focuses on Series A, Series B, Series C+ stage investments.

Related Investors

North Bridge Venture Partners & Growth Equity

Wellesley, United States · 412 deals

Kodiak Venture Partners

Wellesley, United States · 134 deals

Castile Ventures

Wellesley, United States · 44 deals

Venture Capital Fund of New England

Wellesley, United States · 34 deals

Inflection Point Ventures

Wellesley, United States · 19 deals

Walnut Venture Associates

Wellesley, United States · 10 deals